
HealthMark Named a Top Workplace in 2025 by USA Today
HealthMark Group celebrates another year as a USA Today Top Workplace honoree, which recognizes companies nationwide taking the lead in employee satisfaction DALLAS,... Read more.

Ocho Sends Letter to the Board of Digimarc Corporation
Calls for CEO Search by a Committee of Independent Directors AUSTIN, Texas, March 20, 2025 /PRNewswire/ — Ocho Investments LLC (“Ocho”), which... Read more.

Grain Management Enters Exclusive Arrangement to Acquire 800 MHz Spectrum Portfolio from T-Mobile, with Plan to Support Critical Utility Communications
Black & Veatch to serve as exclusive sales agent and industry partner WASHINGTON, March 20, 2025 /PRNewswire/ — Grain Management, LLC (“Grain”),... Read more.

Government of Canada finalizes investment to support Canadian-Born AI leader, Cohere
Investment will boost domestic compute capacity to strengthen the Canadian AI ecosystem OTTAWA, ON, March 20, 2025 /CNW/ – Today, the Honourable Anita Anand,... Read more.

U.S. FDA approves TREMFYA® (guselkumab), the first and only IL-23 inhibitor offering both subcutaneous and intravenous induction options, for adult patients with moderately to severely active Crohn’s disease
TREMFYA® is the only IL-23i to demonstrate clinical remission and endoscopic response, both at one year, with a fully subcutaneous induction regimen Supported by... Read more.

Nektar Therapeutics to Participate in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference
SAN FRANCISCO, March 20, 2025 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR) today announced that the company will be webcasting its participation in the... Read more.

Studying Worms to Revolutionize Wastewater Treatment: The Science Behind Vermifiltration at the Vermitech Innovation Center
WALLA WALLA, Wash., March 20, 2025 /PRNewswire/ — https://perca.net/ As industries and municipalities seek sustainable solutions for wastewater treatment,... Read more.

Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2024 Results and Provides Corporate Update
LOS ANGELES, March 20, 2025 /PRNewswire/ — Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a clinical-stage... Read more.

Honda North Receives the American Honda President’s Award
Honda North Secures 17th President’s Award from American Honda DANVERS, Mass., March 20, 2025 /PRNewswire/ — Honda North, a flagship member of the ICL... Read more.

EARTHX ANNOUNCES 9TH ANNUAL E-CAPITAL SUMMIT: CATALYZING ENVIRONMENTAL SUSTAINABILITY AND RESILIENCE THROUGH INVESTMENT AND INDUSTRY INNOVATION
DALLAS, March 20, 2025 /PRNewswire/ — International environmental non-profit EarthX is proud to announce it will host the 9th Annual E-Capital Summit from... Read more.